SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-293435
Filing Date
2022-11-28
Accepted
2022-11-28 16:41:10
Documents
11
Period of Report
2022-11-22

Document Format Files

Seq Description Document Type Size
1 20-F d395531d20f.htm 20-F 178661
2 EX-1.1 d395531dex11.htm EX-1.1 177278
3 EX-4.2 d395531dex42.htm EX-4.2 32021
4 EX-4.16 d395531dex416.htm EX-4.16 75009
5 EX-8.1 d395531dex81.htm EX-8.1 2255
6 EX-15.1 d395531dex151.htm EX-15.1 317197
7 EX-15.2 d395531dex152.htm EX-15.2 1380
8 EX-15.3 d395531dex153.htm EX-15.3 1538
9 EX-15.4 d395531dex154.htm EX-15.4 1547
10 GRAPHIC g395531dsp7.jpg GRAPHIC 1808
11 GRAPHIC g395531snap121.jpg GRAPHIC 1433
  Complete submission text file 0001193125-22-293435.txt   792716
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41562 | Film No.: 221426053
SIC: 2834 Pharmaceutical Preparations